Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The Bayesian model on human papillomavirus vaccination in Italy lacks transparency.

Garattini L, van de Vooren K.

Med Care. 2013 Apr;51(4):374. doi: 10.1097/MLR.0b013e3182836de8. No abstract available.

2.

Transparency or proper study valuation procedures missed?

Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P, Mennini FS.

Med Care. 2013 Apr;51(4):374-8. doi: 10.1097/MLR.0b013e31828a6a1e. No abstract available.

3.

Confirming our previous comments.

Garattini L, Casadei G.

Vaccine. 2010 Jan 22;28(4):880. doi: 10.1016/j.vaccine.2009.10.139. Epub 2009 Nov 25. No abstract available.

PMID:
19925905
4.

Anti-HPV vaccination: a review of recent economic data for Italy.

Mennini FS, Costa S, Favato G, Picardo M.

Vaccine. 2009 May 29;27 Suppl 1:A54-61. doi: 10.1016/j.vaccine.2009.02.052. Review.

PMID:
19480963
5.

Cost-effectiveness analysis of Human Papillomavirus (HPV) vaccination in the Netherlands: recent publication reinforces favorable cost-effectiveness despite misleading conclusion.

Postma MJ.

Vaccine. 2010 Jan 22;28(4):873-4. doi: 10.1016/j.vaccine.2009.10.109. Epub 2009 Nov 5. No abstract available.

PMID:
19896454
6.

Universal human papillomavirus vaccination of Australian boys - neither cost-effective nor equitable.

Massey PD, Durrheim DN.

Med J Aust. 2012 Apr 16;196(7):446. No abstract available.

PMID:
22509874
7.

Ladies first: should boys be vaccinated against HPV?

Leon R.

Can Fam Physician. 2008 Jul;54(7):967-8, 972-3. English, French. No abstract available.

8.

The economic impact of HPV vaccines: not just cervical cancer.

Myers ER.

Am J Obstet Gynecol. 2008 May;198(5):487-8. doi: 10.1016/j.ajog.2008.03.056. No abstract available.

PMID:
18455522
9.

The role of optimal control in assessing the most cost-effective implementation of a vaccination programme: HPV as a case study.

Brown VL, Jane White KA.

Math Biosci. 2011 Jun;231(2):126-34. doi: 10.1016/j.mbs.2011.02.009. Epub 2011 Mar 4.

PMID:
21377481
10.

Free school-based vaccination with HPV vaccine in a Japanese city.

Fujiwara H, Suzuki M, Yoshinari T, Shiiya K.

Vaccine. 2011 Sep 2;29(38):6441-2. doi: 10.1016/j.vaccine.2011.06.031. Epub 2011 Jun 23. No abstract available.

PMID:
21704106
11.

HPV vaccination for boys? Talking economic sense.

Garattini L, van de Vooren K.

J Sex Med. 2012 Aug;9(8):2195-6. doi: 10.1111/j.1743-6109.2012.02828.x. Epub 2012 Jul 3. No abstract available.

PMID:
22759792
12.

Response: Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

Rozenbaum MH, Boersma C.

J Natl Cancer Inst. 2010 Mar 3;102(5):358-9; author reply 359-60. No abstract available.

13.

Re: Cost-effectiveness analysis of human papillomavirus vaccination in the Netherlands.

Coupé VM, Meijer CJ, Berkhof J.

J Natl Cancer Inst. 2010 Mar 3;102(5):358; author reply 358. doi: 10.1093/jnci/djp372. Epub 2009 Oct 27. No abstract available.

14.

Novel health economic evaluation of a vaccination strategy to prevent HPV-related diseases: the BEST study.

Favato G, Baio G, Capone A, Marcellusi A, Costa S, Garganese G, Picardo M, Drummond M, Jonsson B, Scambia G, Zweifel P, Mennini FS.

Med Care. 2012 Dec;50(12):1076-85. doi: 10.1097/MLR.0b013e318269e06d. Erratum in: Med Care. 2013 Apr;51(4):378.

PMID:
22922435
15.

Challenges of implementing human papillomavirus (HPV) vaccination policy.

Raffle AE.

BMJ. 2007 Aug 25;335(7616):375-7. Review. No abstract available.

16.

Vaccinate boys as well as girls against HPV: it works, and it may be cost effective.

Prue G.

BMJ. 2014 Jul 29;349:g4834. doi: 10.1136/bmj.g4834. No abstract available.

PMID:
25073786
17.

A novel method to value real options in health care: the case of a multicohort human papillomavirus vaccination strategy.

Favato G, Baio G, Capone A, Marcellusi A, Saverio Mennini F.

Clin Ther. 2013 Jul;35(7):904-14. doi: 10.1016/j.clinthera.2013.05.003. Epub 2013 Jun 24.

PMID:
23806328
18.

Cost-effectiveness of human papilloma virus vaccination in Iceland.

Oddsson K, Johannsson J, Asgeirsdottir TL, Gudnason T.

Acta Obstet Gynecol Scand. 2009;88(12):1411-6. doi: 10.3109/00016340903322750.

PMID:
19900074
19.

Low affordability may limit the effect of cervical cancer vaccination in central and eastern European countries.

Zubor P, Danko J, Kajo K, Szunyogh N.

J Clin Oncol. 2007 Dec 1;25(34):5534-7. No abstract available.

20.

A brief history of economic evaluation for human papillomavirus vaccination policy.

Beutels P, Jit M.

Sex Health. 2010 Sep;7(3):352-8. doi: 10.1071/SH10018.

PMID:
20719227
Items per page

Supplemental Content

Write to the Help Desk